These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 17393746)

  • 21. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
    Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
    Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year).
    Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G
    Pediatr Allergy Immunol; 2007 Feb; 18(1):58-62. PubMed ID: 17295800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis.
    Bordignon V; Burastero SE
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):158-63. PubMed ID: 16937744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
    Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
    Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sublingual immunotherapy in the treatment of children.
    Pham-Thi N; de Blic J; Scheinmann P
    Allergy; 2006; 61 Suppl 81():7-10. PubMed ID: 16792599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.
    Kim JM; Lin SY; Suarez-Cuervo C; Chelladurai Y; Ramanathan M; Segal JB; Erekosima N
    Pediatrics; 2013 Jun; 131(6):1155-67. PubMed ID: 23650298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
    Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
    J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
    Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublingual immunotherapy in the context of a clinical practice improvement program in the allergological setting: results of a long-term observational study.
    Marogna M; Massolo A
    Eur Ann Allergy Clin Immunol; 2003 Apr; 35(4):133-40. PubMed ID: 12793117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
    Novembre E; Galli E; Landi F; Caffarelli C; Pifferi M; De Marco E; Burastero SE; Calori G; Benetti L; Bonazza P; Puccinelli P; Parmiani S; Bernardini R; Vierucci A
    J Allergy Clin Immunol; 2004 Oct; 114(4):851-7. PubMed ID: 15480326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age and indications to SLIT.
    Terracciano L; Calcinai E; Avitabile S; Galli E
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):5-8. PubMed ID: 19944002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A localized reaction to sublingual immunotherapy].
    Aarnoudse AL; van den Berge H; Bijl AM; Stricker BH
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1632-4. PubMed ID: 16901069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
    Kleine-Tebbe J; Ackermann-Simon J; Hanf G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.